ClinicalTrials.Veeva

Menu

PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program

University of California San Diego logo

University of California San Diego

Status

Withdrawn

Conditions

Disease, Chronic

Treatments

Other: PharmD TOC
Other: Usual Care

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Many hospitals and medical groups have developed transitions of care (TOC) programs or procedures in an attempt to reduce hospital readmission and reutilization rates of patients discharged from the hospital. As healthcare's most accessible practitioners, Community Pharmacists have a unique opportunity to assist with reducing unnecessary hospital re-utilization (re-admissions and emergency department visits) after hospital discharge. The purpose of this study is to conduct and evaluate the implementation of a Community Pharmacy-based Transitions of Care (TOC) Program for high-risk post-discharge patients of PIH Health Hospital-Whittier (PIH). The primary objective will be to compare the proportion of patients with hospital re-utilization (readmission, observation status, ED visits) during 30-days post hospital discharge between patients randomly assigned to the PHARMD-TOC group vs. the historic rate at PIH. Secondary analyses will examine differences between groups and describe implementation details of the PHARMD-TOC model of patient care.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    • Admission LACE Score: in moderate range (5 to 9) And
  • Taking high risk medication(s): anticoagulants, insulin, oral antiplatelet agents, oral hypoglycemic agents, opioid analgesics, digoxin Or Taking at least 5 medications AND have one of following: CHF, COPD, Asthma, Pneumonia, Diabetes, ESRD, Schizophrenia, Bi-Polar, Dizziness, History of Falls

And

  • Medical or Surgical Unit patients
  • Age > 18 years
  • Being discharged to home (with or without Home Health services)
  • English and/or Spanish speaking
  • Will have access to a telephone post-discharge
  • Ability to give consent
  • Patient admitted to hospital through the emergency department, as a direct admission or as a transfer, or as an elective surgery patient

Exclusion criteria

    • Patients with observation status
  • Caremore Health Plan patients (Caremore has a separate post-discharge program)
  • Patients discharged and followed up by the PIH Coumadin Clinic
  • Patients discharged to Residential MD House Calls program
  • Patients discharged to Skilled Nursing Facility
  • Anyone with planned readmissions
  • Obstetrics patients
  • Hospice patients
  • Oncology patients
  • Anyone who does not meet provisions of protocol
  • Anyone unwilling or unable to give consent for study procedures and data access

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

PHARMD-TOC i
Experimental group
Description:
PharmD Follow-Up Post Discharge
Treatment:
Other: PharmD TOC
USUAL CARE
Active Comparator group
Description:
Usual Post Discharge Procedures
Treatment:
Other: Usual Care

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems